Literature DB >> 1921404

Prognostic factors in laryngeal cancer patients submitted to surgical treatment.

L P Kowalski1, E L Franco, J de Andrade Sobrinho, B V Oliveira, P L Pontes.   

Abstract

The authors studied some demographic, clinical, pathologic, and therapeutic variables in relation to the disease-free interval (DFI) and to the overall survival of laryngeal cancer patients. The patient population consisted of 278 consecutive cases of primary laryngeal cancer who had been admitted to four head and neck surgery services in Sao Paulo and Curitiba (Brazil) between 1973 and 1986. All patients had surgical treatment. Although several variables exhibited individual associations with survival, only a few were deemed to have independent prognostic value using multivariate regression techniques based on Cox's proportional hazards model. The primary tumor stage (T index) represented the variable with the highest predictive strength with respect to survival. Hazard ratios for the risk of disease recurrence were 2.3 (T2-3 vs. T1) and 4.3 (T4 vs. T1). Hazard ratios for the risk of death were 1.6 (T2-3 vs. T1) and 3.3 (T4 vs. T1). The following additional factors were also independently associated with the DFI: age, site of primary tumor (transglottic, glottic, or supraglottic), extracapsular spread of lymph node metastasis, surgical margins, type of paratracheal node dissection, and prior tracheostomy. Except for extracapsular spread, the same factors related to the DFI were also significantly related to the overall survival. Race, sex, N-stage, vascular embolization, and histological grade were other independent predictors of the risk of death.

Entities:  

Mesh:

Year:  1991        PMID: 1921404     DOI: 10.1002/jso.2930480204

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  The role of tumor size and patient's age as prognostic factors in laryngeal cancer.

Authors:  K Markou; J Goudakos; S Triaridis; J Konstantinidis; V Vital; A Nikolaou
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

2.  Clinical and molecular prognostic factors in operable laryngeal cancer.

Authors:  Konstantinos Vlachtsis; Angelos Nikolaou; Konstantinos Markou; George Fountzilas; Ioannis Daniilidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

3.  Chromosomal imbalances exclusively detected in invasive front area are associated with poor outcome in laryngeal carcinomas from different anatomical sites.

Authors:  Eliane Papa Ambrosio; Cássia Gisele Terrassani Silveira; Sandra Aparecida Drigo; Vivian de Souza Sacomano; Miriam Coelho Molck; Rafael Malagoli Rocha; Maria Aparecida Custódio Domingues; Fernando Augusto Soares; Luiz Paulo Kowalski; Silvia Regina Rogatto
Journal:  Tumour Biol       Date:  2013-06-08

4.  Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Laryngeal Carcinoma.

Authors:  Beyhan Yılmaz; Engin Şengül; Aylin Gül; Ulaş Alabalık; Fazıl Emre Özkurt; Mehmet Akdağ; İsmail Topçu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-08-29

5.  Genetic characterization of vocal fold lesions: leukoplakia and carcinoma.

Authors:  Rebecca S Bartlett; W Wesley Heckman; Jason Isenberg; Susan L Thibeault; Seth H Dailey
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

6.  Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery.

Authors:  Shih-Wei Yang; Wei-Chieh Chao; Yun-Shien Lee; Liang-Che Chang; Tsan-Yu Hsieh; Tai-An Chen; Cheng-Ming Luo
Journal:  Lasers Med Sci       Date:  2016-09-29       Impact factor: 3.161

7.  MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.

Authors:  Yuan Lv; Dong Ye; Shijie Qiu; Jian Zhang; Zhisen Shen; Yi Shen; Hongxia Deng
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.976

Review 8.  Prognostic impact of perineural invasion in oral cancer: a systematic review.

Authors:  Debora Modelli Vianna Ocampo Quintana; Rogerio Aparecido Dedivitis; Luiz Paulo Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-02       Impact factor: 2.618

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.